Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The study investigates the effect of glucagon-like peptide receptor 1 agonist, liraglutide,
on insulin secretion. Study hypothesis: the effect of liraglutide on insulin release may
change after repeated administration. The effect of liraglutide on insulin release will be
tested using graded glucose infusion test (GGIT) in healthy volunteers. GGIT will be
performed without medication and repeated 12 hours after first dose of liraglutide and after
3 weeks of treatment with liraglutide.